Hata, K.; Nakamura, K.; Maeda, S.; Maeda, M.; Fujio, Y.; Hirobe, S.
Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study. Clin. Pract. 2024, 14, 377-387.
https://doi.org/10.3390/clinpract14020029
AMA Style
Hata K, Nakamura K, Maeda S, Maeda M, Fujio Y, Hirobe S.
Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study. Clinics and Practice. 2024; 14(2):377-387.
https://doi.org/10.3390/clinpract14020029
Chicago/Turabian Style
Hata, Keiko, Keina Nakamura, Shinichiro Maeda, Makiko Maeda, Yasushi Fujio, and Sachiko Hirobe.
2024. "Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study" Clinics and Practice 14, no. 2: 377-387.
https://doi.org/10.3390/clinpract14020029
APA Style
Hata, K., Nakamura, K., Maeda, S., Maeda, M., Fujio, Y., & Hirobe, S.
(2024). Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study. Clinics and Practice, 14(2), 377-387.
https://doi.org/10.3390/clinpract14020029
